欧洲疾控中心-欧洲艾滋病毒预防和护理标准_暴露前预防模块（英）-2025_28页_1mb

ECDC PrEP Standards Summary

This report outlines European standards for HIV prevention through pre-exposure prophylaxis (PrEP). It emphasizes equitable access, safety, adherence, integration services, training, and monitoring.

Key Findings

• Access: All at-risk individuals should have equitable access to PrEP, with 100% of European countries encouraged to offer and fund PrEP fully.
• Initiation & Safety:
  • HIV testing must precede PrEP initiation.
  • Hepatitis B vaccination is mandatory for PrEP users who are not immune.
  • Alternative PrEP regimens are available for specific safety needs.
• Continuum & Adherence:
  • Adherence is monitored using clinical and self-reported methods.
  • Long-term adherence supports effective prevention.
  • Post-exposure prophylaxis (PEP) must be readily available for high-risk exposure without current PrEP use.
• Delivery & Integration:
  • PrEP services may use telehealth but must maintain rigorous safety protocols.
  • Integrated services include STI screening, immunizations (e.g., HAV, HPV, MPOX), and linkage to care.
• Monitoring & Evaluation:
  • Countries must establish protocols for tracking coverage, adherence, and outcomes.
  • Data collection via national systems enhances program effectiveness.

Target Indicators Highlighted

• PrEP Coverage: Percentage of countries with system-funded PrEP (target: 100%).
• HIV Safety: Reliable HIV testing before PrEP initiation (target: 95%).
• Vaccination: Hepatitis B vaccination rates for PrEP users (target: 80%).
• Adherence: Documentation of adherence assessment for PrEP users (target: 80%).
• Integration: Availability of combined prevention strategies (target: 80-90%).

These standards aim to enhance HIV prevention across Europe through standardized guidelines, robust monitoring, and equitable access.